About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Scripps MD Anderson Cancer Center
https://www.Scripps.org/HemOncCME
Clinical Hematology & Oncology 2024
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
2023 Cancer Care Symposium
2023 Oncology Update
Clinical Hematology & Oncology 2023
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2022 Cancer Care Symposium
Clinical Hematology & Oncology 2022
Melanoma 2022: 32nd Annual Cutaneous Malignancy Update
2021 Cancer Care Symposium
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Nonmalignant Hematology
Malignant Hematology
Updates in Oncology
Breast Cancer Updates
Event Info
Eighth Annual Scripps Cancer Care Symposium
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Diagnosis and Management of Melanoma
Cases
Event Info
7th Annual Scripps Cancer Care Symposium
Survivorship and Palliative Care
Cancer and Cardiovascular Disease
Immunotherapy
Ethics, Genetics and Society
Debates
Event info
2019 Oncology Update
2019 Oncology Update Videos
Event info
Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Melanoma 2019: 29th Annual Cutaneous Malignancy Update Videos
Event Info
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Malignant Hematology
Nonmalignant Hematology
Updates in Oncology
Topics in Cancer
Event Info
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Management of Dysplastic Nevi: What Is the Best Way to Biopsy? Should They Be Re-excised?
By
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
FEATURING
Benjamin Kelley
By
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
FEATURING
Benjamin Kelley
7 views
March 6, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Diagnosis and Management of Melanoma
18:34
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Melanoma Art and Science, Yesterday and Today: Early History & F…
Feat.
J. Patterson
12:30
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Melanoma Art and Science, Yesterday and Today: Overview of the Advan…
Feat.
J. Patterson
16:10
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Melanoma Art and Science, Yesterday and Today: Overview of the More …
Feat.
J. Patterson
21:50
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Pathology of Melanoma: Overview of Morphologic Subtypes, Staging &am…
Feat.
C. S. Humberson
30:18
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Overview of Dermoscopy and New Diagnostic Techniques in Melanoma
Feat.
T. Blalock
20:17
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
The Evidence for a Large Role of UV Exposure in the Development of C…
Feat.
A. Wysong
16:08
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Dysplastic Nevi: Why Are They Important, Clinical & Histologic C…
Feat.
B. Kelley
06:45
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Management of Dysplastic Nevi: What Is the Best Way to Biopsy? Shoul…
Feat.
B. Kelley
22:07
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
2020 Update on Sentinel Node Biopsy: Does Early Treatment of Lymph N…
Feat.
M. Ross
16:03
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Is Completion Node Dissection for Positive Sentinel Nodes Necessary?
Feat.
M. Ross
09:26
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
SNL & the Impact on Adjuvant Therapy Decision Making: Early Init…
Feat.
M. Ross
22:33
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
H&N Surgeon’s Perspective on Melanoma Management: Close Surveill…
Feat.
C. Bergeron
21:02
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Neoadjuvant IO and Targeted Therapy for Advanced Resectable Melanoma…
Feat.
M. Ross
08:42
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Neoadjuvant Therapy for Advanced Resectable Melanoma: T-VEC OPTIM Tr…
Feat.
M. Ross
18:02
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
In the Era of Immunotherapy, Is There a Role for Radiation Therapy i…
Feat.
P. Tripuraneni
20:10
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Evaluation of Melanonychia: Complete Surgical Removal of Atypical Le…
Feat.
F. Fish
29:33
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Initial Biopsy Determines the Diagnosis/Staging, Work-up, Treatment,…
Feat.
A. Wysong
29:15
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Practice Changing Data on Adjuvant Therapy in Advanced Stage Melanom…
Feat.
K. Bollin
18:43
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
New Tools for Melanoma Diagnosis: Gene Expression Profiling, Chromos…
Feat.
K. Murphy
08:58
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
New Tools for Melanoma Prognosis: Gene Expression Profiling & Id…
Feat.
K. Murphy
17:09
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Oncolytic IO Intralesional Monotherapy in Melanoma: Greatest Respons…
Feat.
M. Ross
12:28
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Oncolytic IO Intralesional Combination Therapy for Treatment Naive P…
Feat.
M. Ross
21:49
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Overview of Metastatic Evaluation of the Melanoma Patient: Sentinel …
Feat.
D. Winstanley
12:20
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Update on Systemic Therapy for Advanced Melanoma: Long-Term Outcomes…
Feat.
K. Bollin
14:32
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Systemic Therapy for Advanced Melanoma: Long-Term Outcomes of IO in …
Feat.
K. Bollin
17:57
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Cutaneous Adverse Events to CPI Therapy in Melanoma Treatment + Cuta…
Feat.
A. Itkin
20:12
Melanoma 2020: 30th Annual Cutaneous Malignancy Update
Evaluation of the Melanoma Patient for Other Primary Melanoma Lesion…
Feat.
F. Fish
